154 related articles for article (PubMed ID: 37176048)
1. Association of Membranous WNT-1 and Nuclear mTOR with Endometrial Cancer Grade.
Pietrus M; Pitynski K; Waligora M; Milian-Ciesielska K; Ludwin A; Socha MW; Skrzypek K
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176048
[TBL] [Abstract][Full Text] [Related]
2. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma.
Shen Q; Stanton ML; Feng W; Rodriguez ME; Ramondetta L; Chen L; Brown RE; Duan X
Int J Clin Exp Pathol; 2010 Nov; 4(1):13-21. PubMed ID: 21228924
[TBL] [Abstract][Full Text] [Related]
3. CD133 Expression in the Nucleus Is Associated with Endometrial Carcinoma Staging and Tumor Angioinvasion.
Pietrus M; Pitynski K; Waligora M; Milian-Ciesielska K; Bialon M; Ludwin A; Skrzypek K
J Clin Med; 2021 May; 10(10):. PubMed ID: 34063525
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
5. Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas.
Balasenthil S; Broaddus RR; Kumar R
Hum Pathol; 2006 Jun; 37(6):656-61. PubMed ID: 16733204
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
7. Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro.
Darb-Esfahani S; Faggad A; Noske A; Weichert W; Buckendahl AC; Müller B; Budczies J; Röske A; Dietel M; Denkert C
J Cancer Res Clin Oncol; 2009 Jul; 135(7):933-41. PubMed ID: 19107520
[TBL] [Abstract][Full Text] [Related]
8. The role of p27 in endometrial carcinoma.
Nycum LR; Smith LM; Farley JH; Kost ER; Method MW; Birrer MJ
Gynecol Oncol; 2001 May; 81(2):242-6. PubMed ID: 11330957
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
[TBL] [Abstract][Full Text] [Related]
10. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
[TBL] [Abstract][Full Text] [Related]
11. Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway.
Zhu Y; Shen J; Gao L; Feng Y
Oncol Rep; 2016 Apr; 35(4):2391-7. PubMed ID: 26884084
[TBL] [Abstract][Full Text] [Related]
12. WNT5A gene and protein expression in endometrial cancer.
Wasniewski T; Kiezun J; Krazinski BE; Kowalczyk AE; Szostak B; Wierzbicki PM; Kiewisz J
Folia Histochem Cytobiol; 2019; 57(2):84-93. PubMed ID: 31198984
[TBL] [Abstract][Full Text] [Related]
13. Expression of maspin in endometrioid adenocarcinoma of endometrium.
Li HW; Leung SW; Chan CS; Yu MM; Wong YF
Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
[TBL] [Abstract][Full Text] [Related]
14. Relevance of lipogenesis and AMPK/Akt/mTOR signaling pathway in endometrial cancer.
Efsun Antmen S; Canacankatan N; Gürses İ; Aytan H; Erden Ertürk S
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):687-695. PubMed ID: 33577023
[TBL] [Abstract][Full Text] [Related]
15. Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer.
Yoshida Y; Kurokawa T; Horiuchi Y; Sawamura Y; Shinagawa A; Kotsuji F
Eur J Cancer; 2010 Dec; 46(18):3445-52. PubMed ID: 20926288
[TBL] [Abstract][Full Text] [Related]
16. Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin.
Liao X; Siu MK; Au CW; Chan QK; Chan HY; Wong ES; Ip PP; Ngan HY; Cheung AN
Mod Pathol; 2009 Jun; 22(6):839-47. PubMed ID: 19329935
[TBL] [Abstract][Full Text] [Related]
17. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.
Lax SF; Kurman RJ; Pizer ES; Wu L; Ronnett BM
Am J Surg Pathol; 2000 Sep; 24(9):1201-8. PubMed ID: 10976693
[TBL] [Abstract][Full Text] [Related]
18. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of galectin-3 is significantly associated with grade, stage and differentiation of endometrial carcinomas.
Al-Maghrabi J; Abdelrahman AS; Ghabrah T; Butt NS; Al-Maghrabi B; Khabaz MN
Pathol Res Pract; 2017 Apr; 213(4):348-352. PubMed ID: 28215640
[TBL] [Abstract][Full Text] [Related]
20. Proteomic Analysis of Human Endometrial Tissues Reveals the Roles of PI3K/AKT/mTOR Pathway and Tumor Angiogenesis Molecules in the Pathogenesis of Endometrial Cancer.
Liu Z; Hong Z; Qu P
Biomed Res Int; 2020; 2020():5273969. PubMed ID: 32908897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]